Glaxo boosts analytics with Spotfire


Glaxo boosts analytics with Spotfire

Cliff Saran

Pharmaceutical giant GlaxoSmithkline is using software from Spotfire to help researchers gather and understand multiple sources of information.

Spotfire is a provider of interactive analytics software designed to help end-users discover new insights in information. Its Spotfire DecisionSite product is being deployed across the GSK Chemistry Domain area to assist the discovery and development of new products and processes.

The software is being used by GSK’s Chemistry Domain to work with the increasingly large volume of high throughput data coming from its screening programme. GSK’s Chemistry Domain has worked closely with Spotfire’s professional services team to develop custom analytic solutions to meet some of the specific research analytic challenges.

Others users of Spotfire include Unilver, Yakult, Johnson & Johnson , Merck, Pfizer, BP and ABN Amro.

Vote for your IT greats

Who have been the most influential people in IT in the past 40 years? The greatest organisations? The best hardware and software technologies? As part of Computer Weekly’s 40th anniversary celebrations, we are asking our readers who and what has really made a difference?

Vote now at:

Email Alerts

Register now to receive IT-related news, guides and more, delivered to your inbox.
By submitting your personal information, you agree to receive emails regarding relevant products and special offers from TechTarget and its partners. You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

COMMENTS powered by Disqus  //  Commenting policy